M Bertini
-
- Lymphoma Diagnosis and Treatment 27
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 13
- Virus-based gene therapy research 4
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 11
- Oncology top 10%
- Viral-associated cancers and disorders 10
- Hematology top 10%
-
- Lung Cancer Treatments and Mutations 7
-
- RNA Interference and Gene Delivery 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Umberto VitoloAlessandro LevisL ResegottiBarbara BottoRoberto FreiloneLorella OrsucciPaolo M. ComoglioGiuseppe Saglio
- Partner nations
- ItalySwitzerlandArgentina
In The Last Decade
M Bertini
43 papers receiving 878 citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 586
- Genetics 225
- Neurology 252
- Oncology 379
- Hematology 145
Countries citing papers authored by M Bertini
This map shows the geographic impact of M Bertini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bertini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bertini more than expected).
Fields of papers citing papers by M Bertini
This network shows the impact of papers produced by M Bertini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bertini. The network helps show where M Bertini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Bertini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 4 | |
| 2 | 2008 | 15 | |
| 3 | 2003 | 51 | |
| 4 | 2002 | 3 | |
| 5 | 2001 | 19 | |
| 6 | 2000 | 11 | |
| 7 | 1999 | 36 | |
| 8 | 1998 | 79 | |
| 9 | 1997 | 52 | |
| 10 | 1996 | 32 | |
| 11 | 1996 | 50 | |
| 12 | 1996 | 9 | |
| 13 | 1992 | 40 | |
| 14 | Mitoxantrone, etoposide, cisplatin and dexamethasone (MEPD) as salvage chemotherapy in resistant non-Hodgkin's lymphoma. | 1991 | 9 |
| 15 | MACOP-B for advanced stage large cell lymphoma (DLCL). More is better? | 1991 | 1 |
| 16 | 1989 | 12 | |
| 17 | 1989 | 15 | |
| 18 | 1987 | 3 | |
| 19 | 1987 | 14 | |
| 20 | Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour. | 1975 | 12 |
About M Bertini
M Bertini is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology, having authored 44 papers that have together received 901 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (13 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (10 papers), Lung Cancer Treatments and Mutations (7 papers), RNA Interference and Gene Delivery (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (586 citations), Genetics (225 citations) and Neurology (252 citations). M Bertini has collaborated with scholars based in Italy, Switzerland and Argentina. Frequent co-authors include Umberto Vitolo, Alessandro Levis, L Resegotti, Barbara Botto, Roberto Freilone, Lorella Orsucci, Paolo M. Comoglio, Giuseppe Saglio, Andrea Gallamini and Eugenio Gallo. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer, British Journal of Haematology and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.